Sheng Ding is a prominent scientist and entrepreneur with a robust background in pharmaceutical sciences and drug discovery. Currently, Sheng serves as Co-Founder at Tenaya Therapeutics and Fate Therapeutics Inc., and has held leadership roles including Institute Director at the Global Health Drug Discovery Institute and Professor and Dean at the School of Pharmaceutical Sciences at Tsinghua University. With extensive experience as a Senior Investigator at The J. David Gladstone Institutes and a history of co-founding multiple biotech companies, including Stemgent, Inc. and Vivace Therapeutics, Sheng has contributed significantly to the field. Academic credentials include a Ph.D. in Chemistry from The Scripps Research Institute and a prior education at Caltech.
Sign up to view 0 direct reports
Get started